Business · 01/10/2019Updated: 10/17/2026 · 1 min read

FDA Clears KENALOG Ointment for Continued Sale

The US Food and Drug Administration (FDA) has ruled that KENALOG (Triamcinolone Acetonide) ointment, 0.025% and 0.1%, and other related drug products were not withdrawn from sale due to safety or effectiveness concerns, allowing them to remain on the market.